Are Intravenous Treatments Safe? New Research Raises Doubts

German scientists identified serious and previously misunderstood contaminants that bring the safety and efficacy of intravenous treatments into question. In a new report, they show how a common intravenous treatment used to boost blood pressure in patients also contains substances called "advanced glycation end products," which trigger inflammation. This study directly challenges today's prevalent belief that advanced glycation end products are not contaminants.

Read the whole article on Science Daily

More from Science Daily